Table 3.
Compound | Log P | Formulation and feeding status | Species | Percentage (%) of absorbed dose in lymph | Reference |
---|---|---|---|---|---|
Δ4-androstan-17-β-methoxycyclopentyl ether (Δ4-AE) | 6.6 | Long chain triglyceride | Rat | 96.77 | Ichihashi et al. [177] |
2α,3α-epithio-5α-androstan-17-one (KEP) | 3 | Long chain triglyceride | Rat | 7.98 | Ichihashi et al. [177] |
5α-androst-2-en-17-one (KO) | 4.6 | Long chain triglyceride | Rat | 6.49 | Ichihashi et al. [177] |
CI-976 | 5.8 | Long chain triglyceride | Rat | 43 | Hauss et al. [179] |
CI-976 | 5.83 | Triglyceride emulsion | Rat | < 1 | Hauss et al. [179] |
Cyclosporin A | 2.99 | Micellar solution | Rat | ~ 2 | Takada et al. [283] |
Cyclosporin A | 2.99 | Long chain triglyceride | Rat | 2.16 | Ueda et al. [276] |
Dehydrotestosterone-17β-methoxycyclopentyl ether (DHTE) | 5.4 | Long chain triglyceride | Rat | 28.35 | Ichihashi et al. [177] |
Dichlorodiphenyltrichloroethane (DDT) | 6.19 | Triglyceride emulsion | Rat | 15 | Myers and Stella [178] |
Epitiostanol | 4.4 | Long chain triglyceride | Rat | 4.53 | Ichihashi et al. [284] |
Etretinate | 7.8 | Long chain triglyceride | Rat | 25.71 | Nankervis et al. [278] |
Halofantrine | 8.5 | Emulsion | Rat | 12 | Porter et al. [133] |
Halofantrine | 8.5 | Micellar | Rat | 18 | Porter et al. [133] |
Halofantrine | 8.5 | Triglyceride lipid | Rat | 17 | Porter et al. [132] |
Halofantrine | 8.5 | Micellar | Rat | 20 | Porter et al. [132] |
Halofantrine | 8.5 | Long chain triglyceride | Rat | 16 | Caliph et al. [152] |
Halofantrine | 8.5 | Fasted | Dog | 1.3 | Khoo et al. [282] |
Halofantrine | 8.5 | Fed | Dog | 54 | Khoo et al. [94] |
Halofantrine (hydrochloride salt) | 8.5 | Fatty acid/monoglycerol solution | Rat | ~ 5 | Porter et al. [132] |
Halofantrine (hydrochloride salt) | 8.5 | Fed | Dog | 44 | Khoo et al. [282] |
Hexachlorobenzene (HCB) | 6.53 | Triglyceride emulsion | Rat | ~ 3 | Myers and Stella [178] |
Isotretinoin | 6.8 | Long chain triglyceride | Rat | 1.99 | Nankervis et al. [278] |
Lu28-179 | 8 | Triglyceride emulsion | Rat | 4.5 | Neilson et al. [285] |
Mepitiostane (prodrug of Epitiostanol) | 6.06 | Triglyceride | Rat | 41 | Ichihashi et al. [243] |
Mepitiostane (prodrug of Epitiostanol) | 6 | Long chain triglyceride | Rat | 92.59 | Ichihashi et al. [284] |
Mepitiostaneolefin | 5.1 | Long chain triglyceride | Rat | 97.67 | Ichihashi et al. [177] |
MK-386 | 8.6 | Triglyceride | Rat | 0.1 | Kwei et al. [286] |
MK-386 | 8 | Long chain triglyceride | Rat | 1.67 | Kwei et al. [286] |
Ontazolast | 4 | Triglyceride emulsion | Rat | 1.25 | Hauss et al. [277] |
Ontazolast | 4 | SEEDS | Rat | 0.7 | Hauss et al. [277] |
Ontazolast | 4 | Long chain triglyceride | Rat | 69.6 | Hauss et al. [179] |
p,p-DDT | 6.2 | Long chain triglyceride | Rat | 51.6 | O'Driscoll et al. [281] |
Penclomedine | 5.48 | Triglyceride emulsion | Rat | ~ 3 | Myers and Stella [178] |
Progesterone | 3.9 | Long chain triglyceride | Rat | 0.82 | Ichihashi et al. [177] |
Temarotene | 8.7 | Long chain triglyceride | Rat | 45.67 | Nankervis et al. [278] |
Testosterone | 3.3 | Long chain triglyceride | Rat | 0.11 | Ichihashi et al. [177] |
Testosterone-17-β-methoxycyclopentyl ether | 6.2 | Long chain triglyceride | Rat | 12.48 | Ichihashi et al. [177] |
Vitamin D3 | 7.9 | Triglyceride emulsion | Rat | 19.2 | Liu et al. [287] |